{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:03:40Z","timestamp":1791270220877,"version":"4.1.0"},"reference-count":50,"publisher":"Cold Spring Harbor Laboratory","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Dev."],"published-print":{"date-parts":[[1998,1,15]]},"abstract":"<jats:p>Elevation of p16, the <jats:italic>CDKN2\/p16<\/jats:italic> tumor suppressor gene (TSG) product, occurs at senescence in normal human uroepithelial cells (HUC). Immortal HUCs and bladder cancer cell lines show either alteration of p16 or pRb, the product of the retinoblastoma (<jats:italic>RB<\/jats:italic>) TSG. In addition, many human cancers show p16 or pRb alteration along with other genetic alterations that we associated with immortalization, including +20q and \u22123p. These observations led us to hypothesize that p16 elevation plays a critical role in senescence cell cycle arrest and that overcoming this block is an important step in tumorigenesis in vivo, as well as immortalization in vitro. Using a novel approach, we tested these hypotheses in the present study by examining p16 and pRb status in primary culture (P0) and after passage in vitro of transitional cell carcinoma (TCC) biopsies that represented both superficial bladder tumors and invasive bladder cancers. We demonstrated that all superficial TCCs showed elevated p16 after limited passage in vitro and then senesced, like normal HUCs. In contrast, all muscle invasive TCCs contained either a p16 or a pRb alteration at P0 and all spontaneously bypassed senescence (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). Comparative genomic hybridization (CGH) was used to identify regions of chromosome loss or gain in all TCC samples. The application of a statistical model to the CGH data showed a high probability of elevated alteration rates of +20q11\u2212q12 (0.99) and +8p22\u2212pter (0.94) in the immortal muscle invasive TCCs, and of \u22129q (0.99) in the superficial TCCs. Three myoinvasive TCCs lost 3p13\u2212p14. In this study, four of six myoinvasive TCCs also showed<jats:italic>TP53<\/jats:italic> mutation that associated well with genome instability (<jats:italic>P<\/jats:italic>\u2009=\u20090.001), as previously hypothesized. Notably,<jats:italic>TP53<\/jats:italic> mutation, which has been used as a marker of tumor progression in many human cancers, was less significant in associating with progression in this study (<jats:italic>P<\/jats:italic>\u2009=\u20090.04) than was p16 or pRb alteration (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). Thus, these data support a new model in which overcoming senescence plays a critical role in human cancer pathogenesis and requires at least two genetic changes that occur in several combinations that can include either p16 or pRb loss and at least one additional alteration, such as +20q11\u2212q12, \u22123p13\u2212p14, or \u22128p21\u2212pter.<\/jats:p>","DOI":"10.1101\/gad.12.2.163","type":"journal-article","created":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T22:15:26Z","timestamp":1203545726000},"page":"163-174","source":"Crossref","is-referenced-by-count":107,"title":["Overcoming cellular senescence in human cancer\u2009pathogenesis"],"prefix":"10.1101","volume":"12","author":[{"given":"Thomas R.","family":"Yeager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Jarrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinghai","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Bruskewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine F.","family":"Meisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy W.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic M.","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Reznikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[1998,1,15]]},"reference":[{"key":"2021111418504091000_12.2.163.1","unstructured":"American Cancer Society (1997) Cancer facts and figures\u20141996, 96-300M\u2013No. 5008.96. (American Cancer Society, Bethesda, MD)."},{"key":"2021111418504091000_12.2.163.2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<84::AID-GCC3>3.0.CO;2-W"},{"key":"2021111418504091000_12.2.163.3","first-page":"546","article-title":"Pathology and staging of bladder cancer.","volume":"23","author":"Bane","year":"1996","journal-title":"Semin. Oncol."},{"key":"2021111418504091000_12.2.163.4","doi-asserted-by":"crossref","unstructured":"Belair, C.D., T.R. Yeager, P.M. Lopez, and C.A. Reznikoff. 1997. Telomerase activity: A biomarker for proliferation\u2014not malignant transformation. Proc. Natl. Acad. Sci. (in press)..","DOI":"10.1097\/00005392-199808000-00098"},{"key":"2021111418504091000_12.2.163.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.8023167"},{"key":"2021111418504091000_12.2.163.6","doi-asserted-by":"publisher","DOI":"10.1038\/ng1095-210"},{"key":"2021111418504091000_12.2.163.7","unstructured":"Catalona, W.J. 1992. Urothelial tumors of the urinary tract. InCampbell\u2019s Urology (ed. P.C. Walsh, A.B. Retik, T.A. Stamey, and E.D. Vaughn), Chapter 28, pp. 1094\u20131158. W.B. Sanders, Philadelphia, PA.."},{"key":"2021111418504091000_12.2.163.8","first-page":"1217","article-title":"Cooperative effects of p53 and pRb alteration in primary superficial bladder tumors.","volume":"57","author":"Cordon-Cardo","year":"1997","journal-title":"Cancer Res."},{"key":"2021111418504091000_12.2.163.9","doi-asserted-by":"publisher","DOI":"10.1101\/SQB.1994.059.01.010"},{"key":"2021111418504091000_12.2.163.10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.20.9363"},{"key":"2021111418504091000_12.2.163.11","doi-asserted-by":"crossref","unstructured":"Efron B. Tibshirani R. (1993) An introduction to the bootstrap. (Chapman and Hall, London, UK).","DOI":"10.1007\/978-1-4899-4541-9"},{"key":"2021111418504091000_12.2.163.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311903"},{"key":"2021111418504091000_12.2.163.13","first-page":"4531","article-title":"Methylation of the 5\u2032 CpG island of the p16\/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.","volume":"55","author":"Gonzalez-Zulueta","year":"1995","journal-title":"Cancer Res."},{"key":"2021111418504091000_12.2.163.14","unstructured":"Harley C.B. (1995) Telomeres and aging. in Telomeres, eds Blackburn E.H. Greider C.W (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), pp 247\u2013263."},{"key":"2021111418504091000_12.2.163.15","first-page":"1","article-title":"The longevity of cultured human cells.","volume":"22L","author":"Hayflick","year":"1974","journal-title":"Assoc. Am. Geriatr. Soc."},{"key":"2021111418504091000_12.2.163.16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1905840"},{"key":"2021111418504091000_12.2.163.17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ijc.2910530409","article-title":"Accumulated allelic losses in the development of urothelial cancer.","volume":"53","author":"Hubuchi","year":"1993","journal-title":"Int. J. Cancer"},{"key":"2021111418504091000_12.2.163.18","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870120309"},{"key":"2021111418504091000_12.2.163.19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types.","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"2021111418504091000_12.2.163.20","first-page":"33","article-title":"A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking and occupational exposure to asbestos.","volume":"5","author":"Kannio","year":"1996","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2021111418504091000_12.2.163.21","first-page":"531","article-title":"Allelotype of human bladder cancer.","volume":"54","author":"Knowles","year":"1994","journal-title":"Cancer Res."},{"key":"2021111418504091000_12.2.163.22","doi-asserted-by":"publisher","DOI":"10.1038\/36462"},{"key":"2021111418504091000_12.2.163.23","doi-asserted-by":"publisher","DOI":"10.1038\/375503a0"},{"key":"2021111418504091000_12.2.163.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.14.6289"},{"key":"2021111418504091000_12.2.163.25","doi-asserted-by":"publisher","DOI":"10.1038\/nm0795-686"},{"key":"2021111418504091000_12.2.163.26","first-page":"2765","article-title":"Chromosome imbalance maps of malignant solid tumors: A cytologic survey of 3185 neoplasims.","volume":"57","author":"Mertens","year":"1997","journal-title":"Cancer Res."},{"key":"2021111418504091000_12.2.163.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80538-3"},{"key":"2021111418504091000_12.2.163.28","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780130805"},{"key":"2021111418504091000_12.2.163.29","first-page":"598","article-title":"Therapy of superficial bladder cancer.","volume":"23","author":"Nseyo","year":"1996","journal-title":"Semin. Oncol."},{"key":"2021111418504091000_12.2.163.30","first-page":"97","article-title":"Overexpressed cyclin D1 protein related to p53 and retinoblastoma proteins in translational cell carcinoma of the urinary tract.","volume":"4","author":"Ohta","year":"1997","journal-title":"Oncology Rep."},{"key":"2021111418504091000_12.2.163.31","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(96)04225-5"},{"key":"2021111418504091000_12.2.163.32","first-page":"5405","article-title":"Molecular genetic alterations in superficial and locally advanced human bladder cancer.","volume":"51","author":"Presti","year":"1991","journal-title":"Cancer Res."},{"key":"2021111418504091000_12.2.163.33","first-page":"263","article-title":"Altered growth patterns in vitro of human papillary transitional carcinoma cells.","volume":"111","author":"Reznikoff","year":"1983","journal-title":"Am. J. Pathol."},{"key":"2021111418504091000_12.2.163.34","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041310302"},{"key":"2021111418504091000_12.2.163.35","doi-asserted-by":"publisher","DOI":"10.1101\/gad.8.18.2227"},{"key":"2021111418504091000_12.2.163.36","first-page":"571","article-title":"A molecular genetic model of human bladder cancer pathogenesis.","volume":"23","author":"Reznikoff","year":"1996","journal-title":"Semin. Oncol."},{"key":"2021111418504091000_12.2.163.37","first-page":"2886","article-title":"Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human urothelial cells.","volume":"56","author":"Reznikoff","year":"1996","journal-title":"Cancer Res."},{"key":"2021111418504091000_12.2.163.38","first-page":"536","article-title":"Bladder cancer epidemiology and pathogenesis.","volume":"23","author":"Ross","year":"1996","journal-title":"Semin. Oncol."},{"key":"2021111418504091000_12.2.163.39","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.1.53"},{"key":"2021111418504091000_12.2.163.40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1200868"},{"key":"2021111418504091000_12.2.163.41","doi-asserted-by":"publisher","DOI":"10.1038\/366704a0"},{"key":"2021111418504091000_12.2.163.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81902-9"},{"key":"2021111418504091000_12.2.163.43","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/bjc.1997.305","article-title":"Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.","volume":"75","author":"Shin","year":"1997","journal-title":"Br. J. Cancer"},{"key":"2021111418504091000_12.2.163.44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201066"},{"key":"2021111418504091000_12.2.163.45","first-page":"784","article-title":"Two molecular pathways to transitional cell carcinoma of the bladder.","volume":"54","author":"Spruck","year":"1994","journal-title":"Cancer Res."},{"key":"2021111418504091000_12.2.163.46","doi-asserted-by":"publisher","DOI":"10.1038\/370183a0"},{"key":"2021111418504091000_12.2.163.47","first-page":"1083","article-title":"Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.","volume":"12","author":"Takle","year":"1996","journal-title":"Oncogene"},{"key":"2021111418504091000_12.2.163.48","doi-asserted-by":"crossref","unstructured":"Vieten, L., C.D. Belair, L. Savelieva, K. Julicher, F. Broker, W. Bardenheuer, and J. Schuttee. 1997. Minimal deletion of 3p13\u2009\u2192\u2009p14.2 associated with immortalization of human uroepithelial cells. Genes, Chrom. Cancer (in press)..","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<39::AID-GCC6>3.0.CO;2-9"},{"key":"2021111418504091000_12.2.163.49","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ijc.2910530513","article-title":"Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression.","volume":"53","author":"Xu","year":"1993","journal-title":"Int. J. Cancer"},{"key":"2021111418504091000_12.2.163.50","first-page":"493","article-title":"Increased p16 levels correlate with pRb alterations in human urothelial cells.","volume":"55","author":"Yeager","year":"1995","journal-title":"Cancer Res."}],"container-title":["Genes &amp; Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/gad.12.2.163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T03:13:53Z","timestamp":1636946033000},"score":1,"resource":{"primary":{"URL":"http:\/\/genesdev.cshlp.org\/lookup\/doi\/10.1101\/gad.12.2.163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1,15]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,1,15]]}},"alternative-id":["10.1101\/gad.12.2.163"],"URL":"https:\/\/doi.org\/10.1101\/gad.12.2.163","relation":{},"ISSN":["0890-9369","1549-5477"],"issn-type":[{"value":"0890-9369","type":"print"},{"value":"1549-5477","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1,15]]}}}